Pacific Health Care Organization Inc (PFHO) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket
 


Pacific Health Care Organization Inc  (NONE: PFHO)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare


Pacific Health Care Organization Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Pacific Health Care Organization Inc's ROI in the second quarter of 2026?
Pacific Health Care Organization Inc achieved a return on average invested assets (ROI) of 7.42 % in its second quarter of 2026, which is below Pacific Health Care Organization Inc's average return on investment, which stands at 12.01%.

ROI fell compared to the first quarter of 2026, despite the net income growth of 68.82% from the first quarter of 2026.

Within the Healthcare sector 27 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 645 to 656.

Definition and Formula of Return on Investment



Return On Investment (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 10.74 % 11.97 % 11.52 % 10.45 % 9.06 %
Y / Y Net Income Change TTM -30.1 % 31.65 % 102.22 % 270.97 % 549.57 %
Investment (TTM) in Millions 14 13 13 13 13
Return On Investment (TTM) 7.42 % 9.95 % 10.98 % 11.79 % 11.75 %
PFHO's Overall Ranking # 656 # 645 # 634 # 578 #
Seq. Investment Change TTM 1.89 % 2.55 % 2.86 % 3.04 % 3.03 %
Seq. Net Income Change TTM -24.05 % -7.13 % -4.2 % 3.44 % 43.05 %
Net Income (TTM) in Millions 1 1 1 1 1




Return On Investment PFHO's Ranking
Within: No.
Industry # 5
Sector # 28
Overall # 656

Return On Investment Statistics
High Average Low
36.99 %
12.01 %
3.84 %
(Sep 30 2015)   (Mar 31 2023)







Financial Statements
Pacific Health Care Organization Inc's II. Quarter Investments $ 14 Millions PFHO's Balance sheet
Pacific Health Care Organization Inc's II. Quarter Income $ 0 Millions Quarterly PFHO's Income Statement
PFHO's Income by Division See PFHO's Income by Division


PFHO Annual Return On Investment (Dec 31 2025)
2025
(Dec 31 2024)
2024
(Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021
Total Investments in Millions 13 12 11 11 11
Y / Y Investment Growth 12.01 % 7.67 % -4.4 % 4.54 % 7.92 %
Net Income in Millions 1 1 1 0 1
Y / Y Net Income Growth 57.04 % 14.83 % 56.12 % -50.46 % 81.05 %
Annual Return On Investment 10.6 % 7.56 % 7.09 % 4.34 % 9.16 %


Annual Roi Comment
In the fiscal year 2025 ROI improved to 10.6 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Healthcare Facilities Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
PFHO's Roi Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for PFHO's Competitors
Subscribers only: Roi for Pacific Health Care Organization Inc's Suppliers
Subscribers only: Return On Investment for PFHO's Customers

Other Ratios
PFHO's Roa PFHO's Inventory Turnover Ratio PFHO's Growth Rates PFHO's Dividend Statistics
PFHO's Profitability Ratios PFHO's Asset Turnover Ratio PFHO's Dividend Growth
PFHO's Roe PFHO's Valuation Ratios PFHO's Financial Strength Ratios PFHO's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI
Chemed Corporation  20.13 %
Resmed Inc   20.01 %
Halozyme Therapeutics Inc   19.99 %
Vertex Pharmaceuticals Inc  19.97 %
Agilent Technologies inc   19.84 %
Illumina Inc   19.61 %
Puma Biotechnology Inc   19.60 %
United Therapeutics Corporation  19.53 %
Zoetis Inc   19.44 %
Krystal Biotech Inc   19.16 %
Carlisle Companies Incorporated  18.88 %
Neurocrine Biosciences Inc   17.51 %
Intuitive Surgical Inc   17.11 %
Theravance Biopharma inc   17.10 %
Standard Biotools Inc   16.38 %
Inspire Medical Systems inc   16.34 %
Aveanna Healthcare Holdings Inc   16.32 %
Harmony Biosciences Holdings inc   15.85 %
Entera Bio Ltd   15.84 %
Nephros Inc   15.31 %
West Pharmaceutical Services Inc   15.29 %
Progyny Inc   15.25 %
Biolife Solutions Inc   14.83 %
Sbc Medical Group Holdings Incorporated  14.78 %
Spero Therapeutics Inc   14.54 %
Insulet Corporation  14.30 %
Alpha Pro Tech Ltd   13.80 %
Bristol myers Squibb Company  13.58 %
Transmedics Group Inc   13.46 %
Strata Critical Medical Inc   13.34 %


Date modified: 2026-08-31T11:54:26+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.